Mark A. Schallenberger is Chief Operating Officer of Xtant Medical Holdings, Inc.. Currently has a direct ownership of 670,866 shares of XTNT, which is worth approximately $449,480. The most recent transaction as insider was on Nov 15, 2025, when has been sold 292,253 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 671K
75.3% 3M change
75.3% 12M change
Total Value Held $449,480

Mark A. Schallenberger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2025
BUY
Grant, award, or other acquisition
-
292,253 Added 30.34%
670,866 Common Stock
Apr 03 2024
BUY
Grant, award, or other acquisition
-
177,551 Added 31.69%
382,695 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
116,144 Added 36.15%
205,144 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
89,000 Added 50.0%
89,000 Common Stock, $0.00000...
MAS

Mark A. Schallenberger

Chief Operating Officer
Belgrade, MT

Track Institutional and Insider Activities on XTNT

Follow Xtant Medical Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XTNT shares.

Notify only if

Insider Trading

Get notified when an Xtant Medical Holdings, Inc. insider buys or sells XTNT shares.

Notify only if

News

Receive news related to Xtant Medical Holdings, Inc.

Track Activities on XTNT